A live archive of receipt-bound excerpts from company earnings calls. No generated thesis, no recommendation — just the recorded language, its source coordinates, and a direct path into the ticker dossier or live Terminal.来自公司财报电话会的可追溯摘录档案。没有生成式投资结论，也没有推荐——只有原始表述、来源坐标，以及进入个股档案或实时终端的直接入口。
Start free in Terminal免费开始使用终端649 verified call records份已核验电话会记录 · 7788 exact facts条精确事实 · 2026-10-26 → 2026-11-01
Browse the full archive page by page. Search on this page by ticker, period, category, or speaker; every card preview is a verbatim call excerpt.分页浏览完整档案。在本页按代码、期间、分类或发言人搜索；每张卡片预览均为电话会原文摘录。
Showing records 6529–6624 of 6702.显示第 6529–6624 条，共 6702 条。
“More importantly, with the growing revenues from operations and ongoing ATM activities, we anticipate adequate cash resources to support operations at least through 2026 by which time we aim to be a fully commercial pharmaceutical company and to own a substantially larger clinical network.”
“And you're going to see revenue goes from $100,000 a month to $200,000 a month to $1 million a month to $2 million a month.”
“We will continue to target an allocation of approximately 75% to 80% of our OpEx to sales and marketing with an aim to maintain reasonably flat G&A spend period-over-period.”
“Transaction revenue was $26.7 million, up slightly from $26.3 million in Q3 on spot volumes of $11.5 billion compared to $16.4 billion in Q3.”
“As we have said before, we anticipate margin for this to be circa 40% Note that our published Flight Path 2030 figures don't include wide-ranging second life opportunities for our batteries.”
“We had gross profit of $1.3 million on that, which we're pretty pleased with given, all the R&D and all the, additional, work that we've been doing, into our systems, and trying to do our best to over-service, our customers.”
“We expect second quarter non-GAAP operating income of $290 million to $300 million, this implies a non-GAAP operating margin of 11.8% to 12.1%.”
“Our annual target assumes 2% to 4% market volume growth.”
“If we first look at the last 3 months of the year, Q4 '25, very, very strong quarter, EUR 167 million in revenue, an increase of EUR 82 million compared to Q4 '25, '24 and with the adjusted utilization of 87% cost of sales is, of course, going up with the delivered vessels.”
“We exceeded the upper end of our revenue guidance, representing approximately 20 times growth over the year.”
“Including the cash impact of capitalized costs, free cash flow in the quarter was $14,000,000 compared to $15,000,000 in the prior year quarter, and as we have noted in the past, we expect our free cash flow to continue to fluctuate from quarter to quarter given the timing of customer and vendor payments.”
“We expect our revenue shaping, cost structure and process improvement actions to be completed towards the earlier end of the 12 to 18-month post-closing time line that we articulated previously, and for the quarter that we just ended to be the low point in terms of margin impact.”
“In 2026, we expect to deliver on our catalysts: preliminary safety and PK data for ABS-201 in the first half, interim 13-week proof-of-concept hair regrowth data in the second half, and initiation of our Phase 2 endometriosis trial in Q4, subject to data and regulatory review.”
“As a result of these decisions, we ended 2025 with strong growth and commercial traction, a healthy backlog and a strong pipeline and with a dramatically strengthened balance sheet, ending the year with $94.4 million.”
“Obviously, given the fact that we are early in a market growth, we are unable to provide guidance for 2026 in numbers, but we can say a lot on what our expectation on the business delivery that will lead to revenue growth significantly in 2026 and 2027.”
“In 2025, we delivered what we set out to do: establish a strong operating foundation with industry-leading costs, strengthen our balance sheet, and take meaningful steps to de-risk our growth pipeline.”
“And after our capital expenditure, which was largely on track to guidance when you take into account some commitments that will roll over year-end, we delivered on our CapEx profile, all resulting in healthy free cash flow of $62,000,000, which was up some 483% on the prior year.”
“Revenues for the year ended December 31, 2025 were $1.2 million as compared to $28.9 million for the full year 2024.”
“Taking a closer look at customer growth, as seen on slide nine, total active customers count increased 73% in 2025.”
“We expect annual production to exceed 220,000 oz over the first 10 years, effectively doubling our current output.”
“Finally, we are excited that activities are progressing under our strategic collaboration with AstraZeneca, which has positively impacted our 2025 revenue.”
“This is the impact that we expect to see from now on, in addition to the impact that we had in the year, which was BRL 1.19 billion in the EBITDA, and then the net profit around BRL 800 million, also with a positive effect in our net profit.”
“Provisions for contingent liability this quarter increased by 343% year-over-year to RMB 1.1 billion, reflecting the growth in loan origination volume under the risk-taking model, which grew by 48% year-over-year.”
“As artificial intelligence continues to expand globally, it is driving significant growth in electricity demands, particularly from data centers and high-performance computing infrastructure.”
“As a result of these cost efficiencies, gross profit dollars grew by $6.4 million or 185% over the prior year, and gross margin grew by two percentage points from 23% to 25% year-over-year.”
“For a list and description of the risks and uncertainties that we face, please see the reports we have filed with the SEC, including in our Annual Report on Form 10-K for the full year ended December 31, 2025, that we filed today.”
“We achieved record full year revenue of $3.9 million, a 20% increase compared to 2024, driven by strong second half momentum with fourth quarter revenue of $1.5 million, representing a 92% increase over the prior year period.”
“Equipment margins in the fiscal 2026 fourth quarter continued to face pressure from softer retail demand and remaining aged inventory; however, margins have improved as inventory has returned toward healthier levels.”
“Regarding cost, interest expense was $19 million, increased by 14% from same quarter last year due to the increase in margin financing and securities lending activities.”
“For the full year, revenue grew more than 17%, driven by strong demand across our core business lines, as well as continued market share gains.”
“As we've noted earlier in the year, we expect the cost optimization and efficiency actions implemented in 2024 and 2025 to yield meaningful savings, and those efforts contributed to improving operating leverage as revenue ramped in the second half.”
“For the full year, net revenue reached RMB 2.02 billion, up 1.5% year-over-year, while net income increased 6.9% to RMB 365.6 million, and the gross margin expanded by 2.9 percentage points to 86.9%.”
“On a full-year basis, we have reaffirmed our outlook for fiscal 2026 adjusted EBITDA of $146 million to $156 million, which includes a partial-year impact of approximately $14 million from the sale-leaseback transactions.”
“Conversely, almost all of the revenue in Q4 was generated by units dispensed to customers, with 6,232 prescribed units in Q4 and $9.1 million in net product revenue.”
“With the strength of our backlog, today we are initiating full year financial guidance with revenue in the range of $3.72 billion-$3.82 billion, representing a 51% increase at the midpoint compared to 2025.”
“Higher sales and gross margin dollars more than offset the increase in operating expenses, resulting in operating income increasing $900,000 to $14,400,000 compared to $13,500,000 in 2025.”
“Importantly, roughly two-thirds of our expected 2026 revenue is already supported by contracted backlog, giving us strong visibility into our outlook.”
“When excluding the impact of the unmitigated I-E-E-P-A or IEEPA tariffs, gross margin increased by approximately 140 basis points to 47% compared to the prior year.”
“When excluding the impact of the unmitigated IEPA tariffs, gross margin increased by approximately 140 basis points to 47% compared to the prior year.”
“For some additional color, we expect our cash usage in the coming quarters to increase slightly from the fourth quarter of 2025 as we continue to invest in the critical parts of our business to support our growth objectives.”
“As a result, we expect an EPS headwind from share dilution based on a Q4 common share equivalent assumption of approximately 242 million shares, bringing our FY '26 expected average to 239 million shares.”
“We open locations in response to customer demand, and our more than 350 organic rental starts since founding, including 85 new rental locations in 2025, reflects a disciplined, repeatable organic growth playbook.”
“For the fourth quarter specifically, our annual outlook implies total sales growth of 13% to 14.5%, which includes the extra fiscal week; same-restaurant sales growth of 3.5% to 5% incorporates the strong trends we have seen through the first three weeks of March; and we expect adjusted diluted net earnings per share between $3.59 and $3.69.”
“Revenue was below guidance due to project sales delayed into 2026 and lower than expected volumes in both solar and storage.”
“Revenue is expected to be in the range of $664.9 million-$678.3 million, and we expect adjusted EBITDA margins of 20% or above.”
“Brand Portfolio gross margin declined 170 basis points to 42%, primarily reflecting a 160 basis point impact from tariffs.”
“Brand portfolio gross margin declined 170 basis points to 42%, primarily reflecting a 160 basis point impact from tariffs.”
“Customer management revenue increased by 1%.”
“Based on the strength of our fourth quarter and full-year 2025 results and the continued execution of our key strategic initiatives, we anticipate 2026 revenue in the range of $2.54 billion to $2.56 billion and adjusted EBITDA in the range of $318 million to $322 million.”
“Our Exchange Services segment already reflects the operating leverage of that architecture with near 70% EBITDA margins driven by near 0 marginal cost on incremental data and recurring revenue economics.”
“And to answer that, I have to go a few steps into 2025, where the market had a very challenging year, with industry volumes down mid- to high-single digits versus 2024, and this happened since the first quarter of the year, with the additional pressure of the increase in beef costs that somehow made us make an adjustment in our strategy.”
“On the product side, revenues was $43 million and product margin negative by 37%, reflecting timing of orders and planned facility upgrades to support upcoming launches.”
“Fourth quarter revenue were $11.8 million, up 60% year-over-year, while full year revenues reached nearly $41 million, up 28%.”
“Our Q3 guidance reflects an estimated 1% to 5% growth in local currency, including about a 1% impact from our Federal business.”
“In the fourth quarter of 2025, net income increased by 15.4% year-over-year to RMB 337.4 million, with net income margin remaining healthy at 28.7%.”
“During 2025, portfolio cash receipts and interest income to XOMA Royalty were greater than the cumulative total of cash OpEx, our Blue Owl loan obligations, and preferred dividend payments, which highlights the potential earnings power of our business model and growth potential from future pipeline assets.”
“We estimate the additional week in fiscal year 2024 contributed approximately 150 basis points to revenue growth and 20 basis points to operating margin on full-year results.”
“Net income attributable to Weibo in the fourth quarter was $66.4 million, representing a net margin of 14% compared to 23% last year, primarily due to above-mentioned impact from operating margin and income tax.”
“Total product sales reached EUR 157.9 million, in line with our guidance, and decreasing by -3.3% over 2024 or -1.3% at constant currency.”
“To summarize the financial picture on a non-GAAP ex maritime basis, Spire delivered 44% Q4 revenue growth, expanded non-GAAP gross margins by five percentage points and improved operating cash flow by 78% and enters 2026 guiding to 50% midpoint core revenue growth with a debt-free balance sheet and a path towards profitability.”
“If we assumed no change in SaaS mix relative to FY 2026, our guidance for revenue growth would be approximately 300 basis points higher, and our adjusted operating margin would be approximately 200 basis points higher.”
“I'm pleased to present Red Cat's financial performance for the fourth quarter and full year 2025, which represents a transformational period in our company's growth trajectory.”
“Our focus at all times has been quality, which was illustrated by the 2 percentage points improvement in margin and our new business profit for full year 2025 grew by 12%.”
“In particular, looking at our adjusted profitability metrics, which mainly excludes stock-based compensation expenses and the recognition of deferred tax assets, we deliver adjusted pre-tax earnings of BRL 241 million, 12.1% above the top end of the guidance for the quarter, and BRL 592 million, 11.5% above the top end of the guidance for the full year.”
“Earlier today, we issued a press release announcing business and pipeline updates and financial results for the three months and full year ended December 31, 2025.”
“For 2026, we expect continued revenue growth in the range of 20% to 25%, supported by our growing pipeline of platform opportunities, increasing customer engagements, higher customer-funded development activities, and a continued transition of development programs into production deployment.”
“We expect fiscal Q3 revenue to be a record $33,500,000,000, plus or minus $750,000,000, gross margin to be approximately 81%, and operating expenses to be approximately $1,400,000,000.”
“We expect tariffs to negatively impact EPS by roughly $0.05-$0.10 and gross margin rate by roughly 40 basis points-60 basis points.”
“From a gross margin perspective, we're initiating FY2026 non-GAAP gross margin guidance of 80%-81%, representing approximately 300 to 400 basis points of expansion year-over-year, driven by continued volume leverage, AI-driven efficiencies, and the increased contribution of higher-margin plaque revenue.”
“On the top line, as I referenced earlier, we are expecting the mechanical factors of the retailer inventory reset, which we expect to improve our organic growth rate about 200 basis points over Q3—so about 50 basis points in the quarter—and then our trade expense timing to carry the rest on the top line.”
“Now, with respect to our outlook for the year, sales are expected to be in the range of $5.2 billion-$5.3 billion, an increase of 10% at the midpoint, and comparable sales growth is expected to be between 3% and 5%, or approximately 17% on a two-year stack basis at the midpoint.”
“Following a 2025 investment cycle, which has overhang into early 2026 as salaries and wages spend from '25 hirings gets annualized, we expect operating leverage acceleration to become evident more towards the second half of the year and then flow into the following year.”
“Notably, we delivered full year adjusted operating income of $65 million, significantly above our guidance range of $50 million-$55 million, driven by an improvement in Q4 sales trends, continued gross profit expansion, and disciplined expense management that resulted in a $26 million reduction in adjusted operating expenses compared to last year.”
“Cost of revenues decreased by 1% year-on-year to RMB 309 million during the fourth quarter, and decreased by 0.4% to RMB 1.2 billion for the full year.”
“If you see a steady level of same-store sales growth in that 2%-4% range over time, we've seen kind of a 20 basis point improvement in operating leverage.”
“For the full year of 2025, China's express delivery industry achieved a steady growth of 13.6%, with volume reaching the 200 billion parcel milestone.”
“In light of the AI wave and also the growing industry competition, what is the, you know, company's strategic growth outlook for 2026, and how does the company plan to capture the opportunities and also address the challenges that arise?”
“In the near term, these measures tightened market liquidity, which in turn suppressed credit demand and put unprecedented pressure on both loan growth and risk management across the industry.”
“We expect to recognize certain one-time severance costs in the first half of 2026, but the net impact of these reductions will result in lower cash burn in the coming quarters and should bring us much closer to profitability in the near term.”
“Again, great partnership and allowed us to facilitate, you know, our growth by essentially allowing us to purchase their 50% of the JV, you know, giving us 100% and full control of the project.”
“I think back to the financial performance, and before turning it back to Michael, if you look at slide four, operationally, and if you look at all the different metrics there starting with the backlog growth, but the delivery, the revenue, getting to the gross margin, I think which is best in class in our market, just, I think, a very good performance that bodes well for how we're gonna be executing in 2026 now and for the next 12, 24, and 36 months.”
“We delivered record-breaking full year net sales of $212.5 million, up 13.7% year-over-year, driven by higher volumes of our Lifeway branded drinkable kefir, as well as strong growth in our Lifeway Farmer Cheese.”
“Looking to 2026, we anticipate gross tariff impact of approximately $380 million with offsets from our enterprise efficiency initiatives of approximately $160 million within gross margin.”
“A 560 basis point decline in overall product margin, driven predominantly by tariff impact and higher markdowns.”
“The WCD market is expanding, KESTRA MEDICAL TECHNOLOGIES, LTD.'s revenue growth accelerated to over 60%, gross margin has increased meaningfully, and we have fortified our balance sheet.”
“In the fourth quarter, we delivered 23% adjusted EBITDA growth and more than 500 basis points of adjusted EBITDA margin expansion while adding a record 550,000 HSAs, resulting in more than 1,000,000 new HSAs from sales for the year, bringing total accounts to 17,800,000 and HSA assets to more than $36,000,000,000.”
“For the full year, our new bookings was over 96,000 square meters or over 300 MW, 3 times the level of the past three years.”
“For the full year of 2025, total revenue reached RMB 4 billion with a gross margin of 11.8%, and adjusted net profit was nearly RMB 200 million.”
“We are closing another strong year and quarter, delivering double-digit growth in revenues, operating profit, EPS, and backlog, which grew by $5.5 billion.”
“For fiscal 2026, non-GAAP gross margin was 82.0%, down 20 basis points on a year-over-year basis a better result than the anticipated full percentage point of headwind in our initial fiscal 2026 guidance as higher revenue partially offset the cloud migration impact.”
“Retail revenue increased 6.6% to $33.6 million due to an 8.3% increase in the volume of water sold to a record 1.09 billion gallons, and this increase resulted from significantly lower rainfalls, in fact, historically low rainfall on Grand Cayman and an approximate 7% increase in the number of customer accounts in our license area.”
“Gross margin increased 20 basis points versus last year to 39.9%, driven by lower markdowns, reflecting the impact of our improved merchandise assortment and value proposition, upgraded allocation process, and our inventory efficiency efforts.”
“Gross margin increased 20 basis points versus last year to 39.9%, driven by lower markdowns reflecting the impact of our improved merchandise assortment and value proposition, upgraded allocation process, and our inventory efficiency efforts.”
“Uruguay returned to growth in the quarter, with traffic up 5% and reaching new heights for both the quarter and the full year.”
“In addition, our outlook incorporates pre-opening costs of $23 million-$24 million, reflecting the potential strategic acceleration of a handful of store openings into early 2027, and a 53rd week impact, which we expect to contribute approximately $40 million in net revenue and $5 million in adjusted EBITDA.”
“Three specific capability additions: over-the-counter trading infrastructure that enables higher-margin execution and larger institutional transactions; stablecoin on- and off-ramps that add payment and settlement fees alongside cross-border transaction volume; and a scalable compliance stack that accelerates client onboarding and drives revenue growth.”
Try a ticker, period, category, or a call speaker.请尝试代码、期间、分类或电话会发言人。
This is a transcript-only, historically incomplete publication. Releases, filings, slides, consensus and price reaction are visibly marked as not joined; lower-evidence packets remain held instead of being inferred.这是仅基于电话会文本且历史覆盖尚不完整的发布。新闻稿、披露文件、演示材料、一致预期和股价反应均明确标注为未接入；证据不足的数据包会被暂缓，而非由推断补齐。